高胆固醇血症治疗前后血小板立体计量学参数的变化
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

广东省卫生厅科研基金(96068)资助


Changes of Platelet Quantitative Stereologic Analysis after Treatment in Patients with Hypercholesterolemia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    为研究高胆固醇血症对血小板超微结构及立体计量学参数的影响及调脂药普伐他汀干预后的变化,选择高胆固醇血症患者2 0例,口服普伐他汀10~2 0mg/d ,疗程4~8周,治疗前后在透射电镜下观察血小板的超微结构并进行立体计量分析。结果发现,治疗后高胆固醇血症患者血清总胆固醇和低密度脂蛋白水平及血小板聚集功能均明显下降,同时血小板形态结构的立体计量学参数得以改善。结果提示,高胆固醇血症患者血小板功能及立体计量学参数的可逆性变化可能与普伐他汀促进动脉粥样斑块消退的机制有关。

    Abstract:

    Aim To study the effect of hypercholesterolemia (HC) on platelet quantitative stereologic parameters and its change after treatment by pravastatin. Methods 20 patients with HC were selected and treated with pravastatin 10~20 mg/d for 4~8 weeks. The changes of platelet ultrastructure were observed by electron microscopic and analysed with quantitative stereologic method. Results After 4~8 weeks treatments, the levels of serum total cholesterol (TC) and platelet aggregation function were lowered and most of platelet quantitative stereologic parameters were improved. Conclusion Altered platelet function and quantitative stereologic parameters with pravastatin therapy in patients with HC can be corrective with its mechanism of enhancing atherosclerosis regression.

    参考文献
    相似文献
    引证文献
引用本文

马丽萍,徐立卓,杨玉芳,尹松梅,聂大年,李志雄,谢双峰,冯坚红.高胆固醇血症治疗前后血小板立体计量学参数的变化[J].中国动脉硬化杂志,2001,9(1):60~63.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2000-05-03
  • 最后修改日期:2000-11-23
  • 录用日期:
  • 在线发布日期: